Clinical Trials Directory

Trials / Completed

CompletedNCT02487914

Evaluation of Pressure Sense Threshold and Tactile Sensation After Lidocaine Iontophoresis Using Interferential Current

Iontophoresis Effects on Senses

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
Female
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

Drug delivery is conducted through various methods such as injection, phonophoresis, and iontophoresis. Iontophoresis is defined as the noninvasive delivery of active ions through epidermis using direct current. The direct current has some disadvantages such as skin burning and limited time of application. Interferential current is a kind of alternating currents without limitations of direct current; so the purpose of this study was to investigate and compare the effects of Lidocaine, interferential current and Lidocaine iontophoresis using interferential current.

Detailed description

Pressure, tactile, and pain thresholds were evaluated before and after the application of Lidocaine, interferential current and Lidocaine iontophoresis using interferential current. Pressure threshold was investigated with a Pesula. Pesula is a pen-like scaled mechanical device that measures the skin pressure threshold. Pesula was pressed to the skin and pressure threshold was measured in mm. Pain and tactile thresholds were investigated using an electrical stimulator.The intensity was gradually increased to the extent that the participant reported a tingling sensation. The displayed intensity was considered as the tactile sense threshold. Then, the intensity was increased to the extent to be intolerable for the participant and this intensity was considered as the maximum pain threshold. The thresholds were recorded in milliampere. Lidocaine iontophoresis using interferential current can increase perception threshold of pain, and pressure sense more significantly in comparison to the application of Lidocaine and interferential current alone.

Conditions

Interventions

TypeNameDescription
DEVICEiontophoresis of Lidocaine 10% with interferential current (Dynatron 438)drug delivery through interferential current.
DRUGLidocaine 10% was sprayed at the identified region
DEVICEinterferential current

Timeline

Start date
2013-01-01
Primary completion
2014-03-01
Completion
2015-03-01
First posted
2015-07-02
Last updated
2015-07-02

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02487914. Inclusion in this directory is not an endorsement.